| 695998 |
FRONTIERS IN ONCOLOGY |
Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway |
2021-05-31 |
10.3389/fonc.2021.707608 |
Frontiers Editorial Office |
| 695997 |
FRONTIERS IN ONCOLOGY |
Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure |
2021-05-31 |
10.3389/fonc.2021.683341 |
Kuo Yuan-Hung, Yen Yi-Hao, Chen Yen-Yang, Kee Kwong-Ming, Hung Chao-Hung, Lu Sheng-Nan, Hu Tsung-Hui, Chen Chien-Hung, Wang Jing-Houng |
| 695996 |
FRONTIERS IN ONCOLOGY |
Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells |
2021-05-31 |
10.3389/fonc.2021.642940 |
Egusquiza-Alvarez Carlos Alejandro, Castañeda-Patlán M. Cristina, Albarran-Gutierrez Sara, Gonzalez-Aguilar Héctor, Moreno-Londoño Angela P., Maldonado Vilma, Melendez-Zajgla Jorge, Robles-Flores Martha |
| 695995 |
FRONTIERS IN ONCOLOGY |
Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma |
2021-05-31 |
10.3389/fonc.2021.668066 |
Zhou Ping, Yu Yi-Feng, Lian Chen-Lu, Wang Jun, Zhuo Ren-Gong, Wu San-Gang |
| 695994 |
FRONTIERS IN ONCOLOGY |
GRK6 Depletion Induces HIF Activity in Lung Adenocarcinoma |
2021-05-31 |
10.3389/fonc.2021.654812 |
Yao Sumei, Ertay Ayse, Zhou Yilu, Yao Liudi, Hill Charlotte, Chen Jinliang, Guan Yangbo, Sun Hui, Ewing Rob M., Liu Yifei, Lv Xuedong, Wang Yihua |
| 695993 |
FRONTIERS IN ONCOLOGY |
N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
2021-05-31 |
10.3389/fonc.2021.681366 |
Zhu Guoqing, Wang Feng, Li Haojie, Zhang Xiao, Wu Qi, Liu Ya, Qian Mingping, Guo Susu, Yang Yueyue, Xue Xiangfei, Sun Fenyong, Qiao Yongxia, Pan Qiuhui |
| 695992 |
FRONTIERS IN ONCOLOGY |
Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a |
2021-05-31 |
10.3389/fonc.2021.679536 |
Liu Hailang, Wang Zhixian, Peng Ejun, Chen Zhiqiang, Tang Kun, Xia Ding |
| 695991 |
FRONTIERS IN ONCOLOGY |
The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up |
2021-05-31 |
10.3389/fonc.2021.683190 |
Yu Young Dong, Ko Young Hwii, Kim Jong Wook, Jung Seung Il, Kang Seok Ho, Park Jinsung, Seo Ho Kyung, Kim Hyung Joon, Jeong Byong Chang, Kim Tae-Hwan, Choi Se Young, Nam Jong Kil, Ku Ja Yoon, Joo Kwan Joong, Jang Won Sik, Yoon Young Eun, Yun Seok Joong, Hong Sung-Hoo, Oh Jong Jin |
| 695990 |
FRONTIERS IN ONCOLOGY |
Immunological Effects of Histotripsy for Cancer Therapy |
2021-05-31 |
10.3389/fonc.2021.681629 |
Hendricks-Wenger Alissa, Hutchison Ruby, Vlaisavljevich Eli, Allen Irving Coy |
| 695989 |
FRONTIERS IN ONCOLOGY |
Multiparametric MRI Features Predict the SYP Gene Expression in Low-Grade Glioma Patients: A Machine Learning-Based Radiomics Analysis |
2021-05-31 |
10.3389/fonc.2021.663451 |
Xiao Zheng, Yao Shun, Wang Zong-ming, Zhu Di-min, Bie Ya-nan, Zhang Shi-zhong, Chen Wen-li |
